BRAINTREE, Mass., April 5, 2016 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that it will host its annual investor and analyst meeting on Tuesday, May 10th from 9:00am to 2:30pm at The State Room, 60 State Street in Boston, Massachusetts.
The agenda for the meeting will include results of the Company's strategic review of its business franchise opportunities, fiscal 2017 guidance and longer-range financial indications.
The meeting is open to analysts, shareholders, and others in the investment community by invitation. Invitations will follow shortly and attendees must register by May 1st. On-line registration will be utilized and instructions for registration will accompany invitations.
Other audiences are welcome to participate in the meeting via live webcast. Webcast details will be posted on the Investor Relations page of our website, www.haemonetics.com.
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help our customers improve patient care and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.
Gerry Gould, VP- Investor Relations
Sandra Jesse, Executive VP
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/haemonetics-sets-date-for-investoranalyst-meeting---may-10-2016-300246498.html
SOURCE Haemonetics Corporation